Neuronetics (STIM) EBITDA Margin Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -430.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 128.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -361.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 102.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 58.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 851.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -313.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 535.00 |
| 10 | Neuronetics | 3.26 Mn | -6.42 Mn | 16.15 Mn | 834.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 834.00 |
| Dec 31, 2025 | 3,893.00 |
| Sep 30, 2025 | 2,208.00 |
| Jun 30, 2025 | 3,057.00 |
| Mar 31, 2025 | 494.00 |
| Dec 31, 2024 | -2,921.00 |
| Sep 30, 2024 | 790.00 |
| Jun 30, 2024 | -998.00 |
| Mar 31, 2024 | 2,437.00 |
| Dec 31, 2023 | 2,067.00 |
| Sep 30, 2023 | -442.00 |
| Jun 30, 2023 | 1,826.00 |
| Mar 31, 2023 | 772.00 |
| Dec 31, 2022 | 353.00 |
| Sep 30, 2022 | 687.00 |
| Jun 30, 2022 | -1,378.00 |
| Mar 31, 2022 | -1,524.00 |
| Dec 31, 2021 | -2,892.00 |
| Sep 30, 2021 | -3,257.00 |
| Jun 30, 2021 | 2,420.00 |
| Mar 31, 2021 | 3,410.00 |
| Dec 31, 2020 | 2,291.00 |
| Sep 30, 2020 | 2,008.00 |
| Jun 30, 2020 | -3,055.00 |
| Mar 31, 2020 | -3,489.00 |
| Dec 31, 2019 | -377.00 |
| Sep 30, 2019 | -801.00 |
| Jun 30, 2019 | -36.00 |
| Mar 31, 2019 | -1,008.00 |
| Dec 31, 2018 | -125.00 |
| Sep 30, 2018 | -475.00 |
| Jun 30, 2018 | -1,451.00 |
| Mar 31, 2018 | 763.00 |